Plasma Fractionation Market to Surpass US$ 26 Billion By 2022

New York, January 04, 2019: The scope of the report includes a detailed study of global and regional markets on Global Plasma Fractionation Market with the reasons given for variations in the growth of the industry in certain regions.

Blood plasma fractionation insinuates the general strategies of disconnecting the distinctive parts of blood plasma, which in this way is a portion of blood got past blood fractionation. The plasma fractionation industry is an area of the Biopharmaceutical business in which the plasma segment of human blood is handled to extricate helpful items. The business is moderately developed, with the center plasma fractionation innovation unaltered. Factors, for example, developing maturing populace, rising rates of draining and insusceptible issue, and developing utilization of immunoglobulin and alpha-1-antitrypsin are the essential development drivers for the worldwide plasma fractionation market.

You Can Browse Full Report:

The Global Plasma Fractionation Market has been segmented as below:

The Global Plasma Fractionation Market is Segmented on the lines of Product Analysis, Application Analysis, End User Analysis and Regional Analysis. By Product Analysis this market is segmented on the basis of Albumin, Immunoglobulin its covers Intravenous Immunoglobulin, Subcutaneous Immunoglobulin & Others. Coagulation Factor Concentrates its covers Factor VIII, Factor IX, Factor XIII, Prothrombin Complex Concentrates & Von Willebrand Factor (VWF). Protease Inhibitors And Other Plasma Fractionation Products. By Application Analysis this market is segmented on the basis of Neurology, Immunology, Haematology, Haemato-oncology, Pulmonology, Rheumatology, Critical Care and Others.

By End User Analysis this market is segmented on the basis of Hospitals and Clinics sector, Clinical Research Laboratories sector and Academic Institutes sector. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include CSL Ltd. (Australia), Grifols S.A (Spain), Baxalta Incorporated (U.S.), Octapharma AG (Switzerland), Kedrion S.p.A (Italy), China Biologic Products, Inc. (China), Biotest AG (Germany), LFB S.A (France), Bio Product Laboratory Ltd. (U.K.), and Sanquin (Netherlands). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Global Plasma Fractionation Market is expected to exceed more than US$ 25.97 Billion by 2022 at a CAGR of 6.7% in the given forecast period.

This report provides:

1) An overview of the global market for Global Plasma Fractionation Market and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans for Global Plasma Fractionation Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

Request Sample Report:

Table of Contents


2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Insights

7 Global Plasma Fractionation Market, By Product

8 Global Plasma Fractionation Market, By Application

9 Global Plasma Fractionation Market, By End User

10 Global Plasma Fractionation Market, By Region

11 Competitive Landscape

11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Situation and Trends
11.3.1 Expansions
11.3.2 Agreements, Collaborations, and Partnerships
11.3.3 New Product Launches
11.3.4 Acquisitions

12 Company Profiles

12.1 Introduction

12.2 CSL Ltd.

12.3 Grifols S.A.

12.4 Baxalta Incorporated

12.5 Octapharma AG

12.6 Kedrion S.P.A

12.7 China Biologic Products, Inc.

12.8 Biotest AG

12.9 LFB S.A.

12.10 Bio Product Laboratory Ltd. (BPL)

2.11 Sanquin

Other Related Market Research Reports:

Preimplantation Genetic Testing Market Size is Projected to be Around US$ 546 Million By 2022

Planting Equipment Market is Expected to Grow US$ 20 Billion By 2022

Phosphate Esters Market is Expected to Grow US$ 1,180.0 Million By 2022

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay


Phone: +1-855-984-1862

Country: United States


Leave a Reply

Your email address will not be published. Required fields are marked *